from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1769/-

LFCtreatmentdescriptionclass of inhibitor

-0.656

Amikacinug/mL Amikacintranslation

0.385

Cap5-10ug/mL Capreomycintranslation

0.019

Rox10-50 ug/mL Roxithromycintranslation

0.128

SM2-5 ug/mL Streptomycintranslation

-1.201

Tet5-10 ug/mL Tetracyclinetranslation

0.429

Rif0.2-5ug/mL Rifampicintranscription

0.111

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.480

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.323

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.609

CPZ10-50 ug/mL Chlorpromazinerespiration

1.814

Clofazimine10-13 ug/mL Clofaziminerespiration

1.175

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.269

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.045

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.420

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.507

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.249

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.082

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.025

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.446

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.923

KCN5-20 ug/mL Potassium cyaniderespiration

1.854

NaN30.2-2 mM Sodium aziderespiration

-1.247

Nigericin50 uM Nigericinrespiration

-0.209

TRC10-150 ug/mL Triclosanrespiration

1.031

TRZ10-25 ug/mL Thioridazinerespiration

-1.042

Valinomycin0.5-10 uM Valinomycinrespiration

-0.306

ZnSO42 mM ZnSO4respiration

-0.844

menadione6-10 ug/mL Menadionerespiration

-0.220

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.145

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.365

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.133

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.058

NRP_1Non-replicating persistence stage 1dosRassociated

0.116

Amp0.2mg/mL AmpicillincellWall

-0.026

Cephalexin20-100 ug/mL CephalexincellWall

-0.066

Cerulenin0.32-5 ug/mL CerulenincellWall

0.922

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.377

EMB10-20 ug/mL EthambutolcellWall

-0.208

Eta12-40 ug/mL EthionamidecellWall

0.006

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.401

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.107

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.719

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.660

BZA0.12 mg/mL BenzamidearomaticAmides

0.043

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.142

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.885

H2O24 mM hydrogen peroxideDNAdamaging

0.357

Levo10 ug/mL LevofloxacinDNAdamaging

-0.593

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.780

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.335

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.020

UVUV-irradiationDNAdamaging

-0.314

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.471

Antimycin12.5-50 ug/mL Antimycin A?

-0.135

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.310

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.334

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.314

PA8240.2-2 ug/mL PA-824?

0.536

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.470

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.888

Verapamil50 uM Verapamil?

-0.328

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.096

methoxatin10-20 ug/mL Methoxatin?